Back
HFA Premium Access

Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry: bridging between the PARADIGM-HF trial, ESC Guidelines and real-world

Session: Late breaking trial IV - Registries
Topic: Pharmacotherapy
Speaker: Doctor C. Kapelios (London, GB)
Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Congress Session

0

About the speaker

Doctor Chris Kapelios

Royal Brompton and Harefield Hospital, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

10 more presentations in this session

Prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary care (PREFER): a pragmatic real world intervention study

Speaker: Professor F. Gustafsson (Copenhagen, DK)

Access
Slides
Video
0
Thumbnail

Discussion - PREFER.

Access
Video
0
Thumbnail

Discussion - PARADIGM-HF.

Access
Video
0
Thumbnail

Clinical presentation, management and 6-month outcome of women diagnosed with PPCM from Europe, Africa, Asia Pacific and Middle East

Speaker: Professor K. Sliwa (Cape Town, ZA)

Access
0
Thumbnail

Discussion - Clinical presentation, management and 6-month outcome of women diagnosed with PPCM from Europe, Africa, Asia Pacific and Middle East.

Access
Video
0
Thumbnail

Access the full session

Late breaking trial IV - Registries

Speakers: Doctor C. Kapelios, Professor F. Gustafsson, Professor K. Sliwa
Access
0
Thumbnail

About the event

Image

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk